Christopher Geven PhD candidateChristopher Geven completed his MSc in Medicine in 2013. In the year thereafter, he worked as a resident physician at the department of Intensive Care of the Radboudumc. Since December 2014, he is a PhD-candidate at the department of Intensive Care Medicine. The main focus of his research is a potential new sepsis drug named Adrecizumab. His research involves experimental studies in both animals and humans as well as clinical trials.
Personal prizes & awards national & international
- 2017: RIMLS Poster award